GANGLIOSIDE GD1b ANTIBODY IgM Test
At DNA Labs UAE, we offer the GANGLIOSIDE GD1b ANTIBODY IgM Test to diagnose autoimmune disorders like Guillain-Barr syndrome (GBS). This test detects the presence of IgM antibodies against the ganglioside GD1b in a person’s blood. Gangliosides are glycolipids found on nerve cells and play a crucial role in cell signaling and communication.
Test Details
The GANGLIOSIDE GD1b ANTIBODY IgM test is performed by taking a blood sample from the patient. The sample, which should be 2 mL (1 mL min.) serum from 1 SST, is shipped refrigerated or frozen. Overnight fasting is preferred, and a duly filled Test Send Out Consent Form is mandatory. The test is conducted using the Enzyme Immunoassay (EIA) method.
Symptoms and Diagnosis
Presence of IgM antibodies against ganglioside GD1b is associated with certain autoimmune diseases, especially Guillain-Barr syndrome (GBS). GBS is a rare neurological disorder characterized by the immune system mistakenly attacking the peripheral nerves, resulting in muscle weakness and paralysis.
The GANGLIOSIDE GD1b ANTIBODY IgM test is typically performed when GBS is suspected. It helps confirm the diagnosis by detecting the specific antibodies involved in the disease. The test results are reported as positive or negative, indicating the presence or absence of GD1b antibodies.
Test Cost
The cost of the GANGLIOSIDE GD1b ANTIBODY IgM test is AED 1100.0.
Report Delivery
The sample should be sent by the 7th of the month, and the report will be delivered after 2-3 weeks.
Pre Test Information
Before taking the test, it is recommended to fast overnight. Additionally, a duly filled Test Send Out Consent Form is mandatory.
Doctor and Test Department
The GANGLIOSIDE GD1b ANTIBODY IgM test is conducted by a neurologist in the OS department.
Importance of the Test
The GANGLIOSIDE GD1b ANTIBODY IgM test is a valuable tool in diagnosing GBS and other related autoimmune disorders. It helps healthcare professionals make informed decisions regarding treatment and management of the condition.
It is important to note that this test is just one component of the diagnostic process for GBS and other autoimmune disorders. Additional tests, such as nerve conduction studies and lumbar puncture, may be required to confirm the diagnosis.
| Test Name | GANGLIOSIDE GD1b ANTIBODY IgM Test |
|---|---|
| Components | |
| Price | 1100.0 AED |
| Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is preferred. Duly filled Test Send Out Consent Formis mandatory. |
| Report Delivery | Sample by 7th of the month; Report after 2??3 weeks |
| Method | EIA |
| Test type | Disorders of Nervous System |
| Doctor | Neurologist |
| Test Department: | OS |
| Pre Test Information | Overnight fasting is preferred. Duly filled Test Send Out Consent Formis mandatory. |
| Test Details |
The GANGLIOSIDE GD1b ANTIBODY IgM test is a diagnostic test used to detect the presence of IgM antibodies against the ganglioside GD1b in a person’s blood. Gangliosides are a type of glycolipid found on the surface of nerve cells and are involved in cell signaling and communication. The presence of IgM antibodies against ganglioside GD1b is associated with certain autoimmune diseases, particularly Guillain-Barr syndrome (GBS). GBS is a rare neurological disorder where the body’s immune system mistakenly attacks the peripheral nerves, leading to muscle weakness and paralysis. The GANGLIOSIDE GD1b ANTIBODY IgM test is typically performed when GBS is suspected. It helps in confirming the diagnosis by detecting the specific antibodies involved in the disease. The test involves taking a blood sample from the patient, which is then analyzed in a laboratory to determine the presence and levels of GD1b antibodies. The test results are reported as positive or negative, indicating the presence or absence of GD1b antibodies. A positive result suggests the likelihood of GBS or another related autoimmune disorder, while a negative result indicates the absence of these antibodies. It is important to note that this test is just one component of the diagnostic process for GBS and other autoimmune disorders. Additional tests, such as nerve conduction studies and lumbar puncture, may be required to confirm the diagnosis. Overall, the GANGLIOSIDE GD1b ANTIBODY IgM test is a valuable tool in diagnosing GBS and other related autoimmune disorders. It helps healthcare professionals make informed decisions regarding treatment and management of the condition. |
